Oncogene (2001) 20, 8299 ± 8307 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc Emc, a negative HLH regulator with multiple functions in Drosophila development Sonsoles Campuzano*,1 1 Centro de BiologõÂa Molecular Severo Ochoa, Cantoblanco, 28049 Madrid, Spain Expression and functional analyses of Emc have demonstrated that it is a prototype for a protein required for multiple processes in development. Initially characterized as a negative regulator of sensory organ development, it was later found to regulate many other developmental processes and cell proliferation. Its ability to block the function of bHLH proteins by forming heterodimers, which are ineective in DNA binding, accounts for the role of Emc in preventing the acquisition of several cell fates which are under the control of bHLH proteins. However, while maintaining this repressive molecular mechanism, emc also appears to act as a positive regulator of dierentiation. Oncogene (2001) 20, 8299 ± 8307 Keywords: Drosophila; extramacrochaetae; HLH; transcription factor; development Identi®cation of extramacrochaetae According to the usual nomenclature system of Drosophila genes, the extramacrochaetae (emc) gene was named after the ®rst discovered phenotype associated to its loss-of-function mutations, i.e., the development of extra sensory organs (SOs) on the adult ¯y. The larval and adult epidermis of Drosophila contains thousands of SOs that are distributed according to a stereotyped pattern. Each SO is formed by the progeny of a single cell, the sensory mother cell (SMC), which, during the third larval instar or early pupal stages, is singled out from the population of imaginal discs cells or abdominal histoblasts (Bate, 1978; Bodmer et al., 1989; Garcõ a-Bellido and Merriam, 1971; Hartenstein and Posakony, 1989). Genetic analysis of loss and gain-of-function mutations in the achaete-scute complex (AS-C) indicated that it was involved in the commitment of epidermal cells to dierentiate as SOs and that the AS-C might be under some type of negative regulation (Garcõ a-Bellido and Santamarõ a 1978; Garcõ a-Bellido, 1979). Back in the early eighties, a genetic screen was performed to identify genes that might negatively regulate the ASC (Botas et al., 1982). The rationale of the screening was that in the presence of extra doses of the AS-C, *Correspondence: S Campuzano; E-mail: scampuzano@cbm.uam.es which by their own do not alter the pattern of SOs, a recessive mutation in a gene encoding a repressor of AS-C would become dominant and promote the generation of extra SOs. That is, only one copy of that gene would not produce enough protein to repress several copies of AS-C and allow a normal pattern of SOs. Mutations that ful®lled this criterion were found in two loci: hairy (h) and the novel emc (Botas et al., 1982). It was further observed that loss of emc function, in a wild type background for the AS-C, caused development of extra SOs, whereas AS-C de®ciencies suppressed this phenotype (Moscoso del Prado and Garcõ a-Bellido, 1984a,b). Taken together, these results suggested that the generation of extra SOs in emc mutants depended on the activity of the AS-C and not on the modi®cation of a parallel developmental pathway. The molecular analysis of AS-C and emc con®rmed this hypothesis and provided a molecular basis for the negative regulation of AS-C by emc. Emc titrates away proneural proteins The achaete (ac) and scute (sc) genes encode proteins which contain the basic ± helix ± loop ± helix domain (bHLH) characteristic of a family of transcriptional regulators (Murre et al., 1989a; Villares and Cabrera, 1987; see Massari and Murre, 2000, for a recent review). Biochemical analysis of mammalian bHLH proteins involved in myogenesis, the MyoD family, and of immunoglobulin enhancer binding bHLH proteins E12 and E47, showed that the HLH domain allows these proteins to form homodimers or heterodimers with other members of the family, while the basic region is required for binding to speci®c DNA sequences (Murre et al., 1989b). ac and sc are expressed at the right place and time to promote SMC determination, as anticipated by the genetic analyses. Both genes are coexpressed in the wing imaginal discs, the anlagen of most of the thorax and the wings, in clusters of cells located at precisely determined positions (Cubas et al., 1991; Romani et al., 1989; Skeath and Carroll, 1991) (Figure 1a). SMCs are born within these clusters of ac ± sc expressing cells (Cubas et al., 1991; Skeath and Carroll, 1991) (Figure 1a). Moreover, removal of speci®c proneural clusters in ac or sc mutants removes the corresponding SMCs and Multiples requirements for Emc in development S Campuzano 8300 Figure 1 Relationship between the pattern of expression of sc (a) and emc (b, c) in the imaginal wing disc and the pattern of SMCs. (a) Imaginal wing disc from an enhancer trap line that expresses lacZ (green) in the SMCs. The distribution of sc mRNA, revealed by in situ hybridization, is shown in purple. Note that SMCs are born within the clusters of sc expressing cells. (b) Pattern of expression of emc. It is fairly complementary to that of sc. Note minima of emc expression at the regions where the SMCs for the DC and SC bristles develop. (c) Expression of emc (purple) and distribution of SMCs (green) in a Hairy wing imaginal wing disc. (Only the prospective wing region is shown). Although sc is ubiquitously expressed in Hairy wing discs (Balcells et al., 1988), expression of emc is not modi®ed (compare with b). Note the development of ectopic SMCs at the posterior wing margin (PWM) that arise within a region of minimal emc expression. Positions of some SMCs is indicated, namely those that will give rise to the anterior notopleural bristle (ANP); anterior postalar bristle (APA); anterior wing margin bristles (AWM); dorsocentral bristles (DC); giant sensilum of the radius (GSR); sensilla of the dorsal radius (Rd); scutellar bristles (SC) and sensilla of the tegula (Td). PWB, posterior wing blade; v3, vein 3 SOs (Cubas et al., 1991; Romani et al., 1989; Skeath and Carroll, 1991) and a generalized distribution of Ac ± Sc products (in Hairy wing mutants) promotes Oncogene development of extra SOs in ectopic positions (Balcells et al., 1988; Skeath and Carroll, 1991). Since AS-C proteins confer on cells the ability to become neural Multiples requirements for Emc in development S Campuzano precursors, the AS-C genes have been called proneural genes and the clusters of cells expressing them are referred to as the proneural clusters (Ghysen and Dambly-ChaudieÁre, 1989; Romani et al., 1989). Another bHLH protein Daughterless (Da), previously identi®ed by its role in sex determination (Cline, 1989) acts synergistically with Ac/Sc to build the SO pattern (Caudy et al., 1988a,b; Dambly-ChaudieÁre et al., 1988). HLH proteins have been classi®ed according to tissue distribution, dimerization capabilities and DNA-binding site speci®city (Massari and Murre, 2000). Due to their restricted pattern of expression, Ac and Sc belong to HLH class II. On the contrary, Da belongs to class I HLH proteins, which show a generalized distribution (Massari and Murre, 2000). Usually, class II HLH proteins activate transcription in the form of heterodimers with class I HLH proteins (Massari and Murre, 2000). Thus, the molecular structure of As ± Sc and Da as well as their genetic interactions (Caudy et al., 1988a,b; Dambly-ChaudieÁre et al., 1988; Villares and Cabrera, 1987) indicated that they are transcriptional regulators that, in combination, control the activity of genes involved in SMC commitment. In agreement with this hypothesis, AS-C proteins and Da can form heterodimers that bind to speci®c DNA sites in vitro (Cabrera et al., 1987; Murre et al., 1989b). emc also encodes a transcription factor of the HLH family, but the Emc protein lacks the basic region that is involved in the interaction with DNA (Ellis et al., 1990; Garrell and Modolell, 1990) and thus, it belongs to class V of HLH proteins (Massari and Murre, 2000). Heterodimers formed by a bHLH protein and an HLH protein devoid of the basic region are unable to bind to DNA (Davis et al., 1990; Voronova and Baltimore, 1990). Since it was already demonstrated that proneural proteins speci®cally bind to DNA in the form of heterodimers (Murre et al., 1989b), a plausible hypothesis for the regulatory interactions between Emc and AS-C was put forward (Figure 2a). Emc would antagonize proneural ac ± sc function by sequestering proneural bHLH proteins in complexes incapable of eective interaction with DNA, rather than by a direct repression of AS-C transcription (Ellis et al., 1990; Garrell and Modolell, 1990, reviewed in Garrell and Campuzano, 1991). This mechanism would account for the dose dependent interactions between emc, as, sc and da, which suggested that a ®nely tuned balance of proneural proteins and of Emc was required for proper SMC determination. It also explained how the gain-of-function emc mutation Achaetous (Ach) caused loss of SOs (Garcõ a-Alonso and Garcõ a-Bellido, 1988): in Ach imaginal discs there is a higher than normal accumulation of emc mRNA and, presumably, of Emc protein (Cubas and Modolell, 1992). This mechanism for EMC action was further supported by the molecular analysis of mouse myogenesis. Emc shows a high degree of similarity to the murine family of Inhibitor of Dierentiation (Id) proteins (Benezra et al., 1990; Ellis et al., 1990; Garrell and Modolell, 1990, reviewed in Norton, 2000). Like EMC, IDs are HLH proteins that lack the basic domain (Benezra et al., 8301 Figure 2 Possible mechanisms for Emc action. (a) Depicts the situation in an SMC. Sc and Da form heterodimers that are able to bind to DNA. The black rectangles indicate that the binding domain of this heterodimer ®ts into the binding site present in the promoter of the target gene. Sc/Emc and Da/Emc heterodimers are unable to bind to DNA (indicated by the white rectangle). Commitment to the SMC fate takes place in cells like that shown in (a) in which the concentration of active heterodimers exceeds that of ineective heterodimers, thus allowing activation of target gene promoter. In this case Emc plays a repressive role. A similar mechanism applies to the activation of Sxl in females. (b and c) represent two possible mechanisms for Emc to function as an activator of certain processes. (b) Represents a mesodermal cell in which Twist (twi) homodimers activate transcription of myogenic genes, while Twist/Da heterodimers, although able to bind to other promoters as indicated by the hatched rectangle, do not active such genes. The presence of Emc may be required for somatic muscle development to titrate away Da, allowing the formation of Twist homodimers. (c) A hypothetical situation in which only A/B heterodimers are able to activate the target gene promoter. The ability of the C protein to sequester B in the form of heterodimers unable to bind to this promoter, is counteracted by the interaction of Emc with C. Note that a similar mechanism may operate in case the productive interaction between (a and b) takes lace after promoter binding. See text for more details about (a and b) Oncogene Multiples requirements for Emc in development S Campuzano 8302 Oncogene 1990) and, similarly to the AS-C regulation of Emc, Id negatively regulated myogenesis through the formation of non-DNA binding complexes with the myogenic bHLH factors (Benezra et al., 1990). The biochemical demonstration that Id can physically interact with members of the bHLH family and attenuate their binding to DNA in vitro, and that in cultured cells Id can inhibit the activation by MyoD of a structural muscle-speci®c gene enhancer, the muscle creatin kinase enhancer (Benezra et al., 1990), provided strong support for the proposed mechanism of action of emc. Thus, biochemical analyses in mammalian cells and genetic data in ¯ies converged into the discovery of a conserved mechanism of regulation of the function of bHLH proteins. Afterwards, it was shown that, indeed, EMC can form heterodimers with proteins of the AS-C and Da and inhibit transcriptional activation of target genes by interfering with their DNA binding ability (Cabrera et al., 1994; Martõ nez et al., 1993; Van Doren et al., 1991). Although Emc regulates proneural protein function, it has been suggested that Emc may repress AS-C transcription indirectly since in emc mutant imaginal wing discs there is an increased accumulation of Sc (Cubas et al., 1991; Cubas and Modolell, 1992). It has been proposed that the eect of Emc on ac ± sc transcription results from its interference with ac and sc self and cross-activation (Martõ nez et al., 1993; Van Doren et al., 1992). Considering that more recent evidence argues strongly against such crossregulatory interactions occurring between the endogenous ac and sc genes (GoÂmez-Skarmeta et al., 1995), alternatives have to be sought to explain the deregulation of sc in emc mutants. A possibility is the promiscuity of Id-family proteins that, not only interfere with the function of bHLH proteins, but can modify the DNA binding ability (either inhibiting or enhancing it) of homeoproteins, ETS proteins and others, and can interfere with the activity of the Rb protein (reviewed in Norton, 2000). Thus, the derepression of sc in emc mutants may result from Emc interfering with the regulation of sc by members of the prepattern, a postulated combination of transcription factors that regulate ac/sc in the imaginal disc (reviewed by Modolell and Campuzano, 1998). The targeted disruption of both Id1 and Id3 genes in mice has demonstrated that these proteins are required for several developmental processes, including neurogenesis (Lyden et al., 1999). Expression of several proneural genes is expanded in such double mutants (Lyden et al., 1999). This observation is consistent with experiments where enforced expression of Id genes inhibited both the activity and expression of bHLH proneural proteins. Given the transcriptional hierarchies that operate within the proneural bHLH family (Kageyama and Nakanishi, 1997), it seems likely that Ids interfere with the regulation of a given proneural bHLH gene by interacting with the product of another bHLH gene located further up in the hierarchy (Lyden et al., 1999). Emc provides positional information for SO patterning The distribution of Ac/Sc in the imaginal discs pre®gures the pattern of SOs, since their precursors, the SMCs, always arise from proneural clusters (Cubas et al., 1991; Skeath and Carroll, 1991) (Figure 1a). However, it has been found that generalized expression of sc under the control of a heat shock promoter in ¯ies devoid of endogenous Ac and Sc promotes development of bristles located at normal positions. This suggested the presence in the imaginal discs of topological cues other than the patterned distribution of Ac and Sc (Rodrõ guez et al., 1990). The spatial distribution of emc RNA suggested that Emc could provide some of these cues (Cubas and Modolell, 1992; Van Doren et al., 1992). In the wing imaginal disc, emc expression is roughly complementary to that of ac/sc (Figure 1b). Moreover, SMCs appear not only within proneural clusters but also within minima of emc expression, a situation that also holds for SMCs developing after generalized sc expression (Cubas and Modolell, 1992) (Figure 1c). Expression of emc is independent of AS-C (Cubas and Modolell, 1992). These observations support a model in which the interactions between proneural proteins and Emc re®ne the spatial distribution of cells with the ability to become SMCs. Within proneural clusters, the levels of Emc would establish a threshold for the amount of Ac/ Sc proteins necessary for a cell to become an SMC. Only cells with levels of proneural proteins sucient to titrate Emc and to activate the downstream genes of the neural dierentiation pathway would be candidates to become SMCs (reviewed in Garrell and Campuzano, 1991). These cells constitute a `proneural ®eld' (Cubas and Modolell, 1992). Interaction among them, mediated by the Notch signaling pathway, is further required to restrict the number of cells that ®nally dierentiate as SMCs (reviewed in Artavanis-Tsakonas et al., 1999). The remaining cells of the proneural clusters would dierentiate as epidermis. Embryonic functions of emc A current theme in development is the reiterative use of the same protein for very dierent processes. For instance, the AS-C proteins and Da are required in neurogenesis, sex determination and myogenesis (Carmena et al., 1995; Garrell and Campuzano, 1991; Jan and Jan, 1993). Similarly, emc is required for multiple processes during Drosophila embryonic and postembryonic development other than the regulation of the pattern of bristles. Only in some cases it has been possible to relate emc requirements with the function of particular bHLH proteins, suggesting that Emc may interfere with the function of non-bHLH proteins. The widespread but not ubiquitous distribution of emc transcripts in the embryo and the embryonic lethality of emc null mutants (Garcõ a-Alonso and Garcõ a-Bellido, 1988) prompted the analysis of the embryonic functions of emc (Cubas et al., 1994; Ellis, 1994). Multiples requirements for Emc in development S Campuzano Emc is supplied maternally as shown by the accumulation of emc mRNA in the ovaries and in the syncytial blastoderm stage (Cubas et al., 1994; Ellis, 1994). This early expression corresponds to a requirement of Emc for sex determination. Sex is determined at this stage by the transcriptional activation of the Sex lethal (Sxl) gene, which is on in females and o in males. The ®rst zygotic transcription of Sxl depends on the X : A ratio, namely, the ratio between the number of X-chromosomes (X) and autosomal sets (A) (Baker, 1989) and on the action of the bHLH protein Da (Cline, 1989). It was determined genetically that the X : A ratio is assessed by the interaction of `numerator elements' present in the X-chromosomes with `denominator autosomal elements' (Cline and Meyer, 1996). The X-linked genes sisterless-a (sis-a), which encodes a bZIP protein (Erickson and Cline, 1993), and sisterlessb, (sis-b) later identi®ed as scute, correspond to numerator elements (Cline, 1988; Erickson and Cline, 1991; Torres and SaÂnchez, 1989, 1991). The critical role of Sc and Da (both bHLH proteins) in sex determination suggested that denominator elements could be negative regulators of bHLH protein activity, similar to Emc, encoded by autosomal genes and thus present in equal amounts in males and females. Only in females, where Sc concentration is twice that in males, enough active Sc/Da heterodimers would be present to overcome the inhibitory eects of the putative autosomal-linked negative regulators and to activate Sxl (Figure 2a). (Da, encoded by an autosomal gene, is present in equal amounts in both sexes). Indeed, overexpression experiments performed in early embryos indicated that Sxl activation depended on the relative concentrations of bHLH X-linked proteins and HLH autosomal-linked proteins (Parkhurst et al., 1990). These data were con®rmed by the identi®cation of emc and deadpan, a class VI HLH protein, as denominator elements (Younger-Shepherd et al., 1992). Hence, the choice of male vs female depends, similar to the commitment to be an SMC or an epidermoblast, on the relative concentration of bHLH and HLH proteins (Figure 2a). During the subsequent stages of embryogenesis, emc is expressed in complex patterns and, accordingly, several developmental processes are aected in emc mutants (Cubas et al., 1994; Ellis, 1994). It is noteworthy that emc mRNA is undetectable in the ectodermal layer from which neuroblasts segregate indicating that, in early embryonic neurogenesis, emc does not regulate proneural function. Consistently, the early patterns of proneural clusters and neural precursors appear normal in emc mutants. Note, however, that emc is expressed at later stages in the developing central nervous system. Correspondingly, before the start of germ ban retraction, emc mutants display disorganized spatial distributions of neuroblasts and their descendants and, later, anomalous axonal patterns (Cubas et al., 1994). emc mRNA accumulates in or adjacent to regions that will undergo morphogenetic movements such as the cephalic and ventral furrows, the amnioproctodeal invagination and the invaginating stomodeum. Although emc mutant embryos do not hatch and their cuticle displays multiple alterations (Cubas et al., 1994), no clear relationship has been established between the pattern of expression of emc and the emc mutant phenotype. Especially informative is the role of emc in the development of the Malpighian tubules, the excretory system of the ¯y, and of the trachea. Both Malpighian tubules and trachea are tubular structures that develop in two steps. In the ®rst one, there is cell proliferation in certain areas of the hindgut or of the ectoderm, respectively, to provide the correct number of cells that will form the ®nal structure. In the second one, there are cell rearrangements, which do not involve cell proliferation, but cell migration and changes of cell shape, which result in formation and elongation of the tubules (Aolter and Shilo, 2000; Skaer, 1993). In the case of the Malpighian tubules, an enlarged cell, the tip cell, appears at the distal part of each developing tubule and directs and patterns cell proliferation through activation of the Epidermal Growth Factor Receptor (EGFR), (Baumann and Skaer, 1993). The tip cell arises from a cluster of ac expressing cells and maintains ac expression after its singling out (Hoch et al., 1994). emc expression precedes and accompanies formation of the Malpighian tubules and, accordingly, emc mutations drastically aect their development. Thus, in emc null mutants, tubules remain as rudiments and contain a reduced number of cells (Cubas et al., 1994; Ellis, 1994). In hypomorphic emc mutants, each tubule rudiment has several extra tip cells (Cubas et al., 1994; Carrera et al., 1998) but these extra cells do not enhance cell proliferation. Moreover, the tubules do not elongate. These results suggest, ®rst, a role of emc in the control of cell proliferation; second, a role in the allocation of the tip cell fate, where emc appears to repress ac function, and third, a role of emc in the cell rearrangements that lead to the elongation of the tubules. With regard to tracheal development, emc is expressed in cells surrounding and including the invaginating tracheal pits, the rudiments of the tracheal tree (Cubas et al., 1994; Ellis, 1994). In emc mutants, the ®nal structure of the tracheal tree is often altered (Cubas et al., 1994). Similar phenotypes are found in mutants for breathless (btl), an FGFR-type transmembrane receptor required for the proper migration of the tracheal cells (Lee et al., 1996). Interestingly, Btl protein levels are reduced in emc mutants (Cubas et al., 1994). Moreover, expression of btl depends on the localized expression of the bHLH-PAS transcription factor trachealess (thl) (Ohshiro and Saigo, 1997). Thus emc, a negative regulator of the function of bHLH proteins, and the bHLH-PAS Thl are coexpressed in the tracheal pit cells and both positively regulate btl. The molecular mechanism for this positive cooperation is at present unknown, but Figure 2 shows several possibilities for Emc modes of action. Interestingly, embryos from Id17/7 ± Id37/7 mice exhibit vascular malformations and the absence of branching and 8303 Oncogene Multiples requirements for Emc in development S Campuzano 8304 sprouting of blood vessels into the neuroectoderm (Lyden et al., 1999). This suggests parallel functions of emc and Id in the formation of tubular structures. Emc is also involved in the development of mesodermal derivatives. The mesoderm develops from the ventral-most cells of the blastoderm. These cells require Twist (Twi), a bHLH protein, for its proper speci®cation (reviewed by Baylies et al., 1998). This region invaginates during gastrulation and is later subdivided into somatic and visceral mesoderm which give rise, respectively, to the body wall muscles (somatic muscles) and the muscles of the gut (visceral muscles) (reviewed in Baylies et al., 1998). emc is expressed at blastoderm stage in the prospective mesoderm; in the mesodermal layer during gastrulation and later, in the muscle attachment sites (apodemes) (Cubas et al., 1994). Accordingly, emc mutations profoundly aect the pattern of somatic muscles, the defects ranging from loss of some muscles to large alterations of this pattern, with muscles forming large masses detached from the epidermis (Cubas et al., 1994). The latter phenotype may be attributed to defective speci®cation of the apodemes. The function of emc in this process may be related to that of Delilah, a bHLH protein that is expressed almost exclusively in the apodemes (Armand et al., 1994). The alteration of the pattern of somatic muscle in emc mutants appears to result from de®cient twi function. First, levels of Twist are decreased in emc embryos (Cubas et al., 1994). Second, Emc may be indirectly required for Twi function (Castanon et al., 2001) (Figure 2b). Twist can form homodimers and heterodimers with Da in vitro (Castanon et al., 2001). Interestingly, in vivo analysis indicates that whereas Twist homodimers specify mesodermal fate, Twist-Da heterodimers repress expression of genes required for somatic myogenesis (Castanon et al., 2001). Considering these data and the previous observation that Emc can heterodimerize with Da (Cabrera et al., 1994; Martõ nez et al., 1993; Van Doren et al., 1991), during somatic muscle development Emc would be required to relieve inhibition of Twist by Da, by sequestering Da as Emc-Da heterodimers (Figure 2b). emc is also expressed in the cells of the visceral mesoderm while they are spreading over the midgut and indeed, cells of the visceral mesoderm showed a clear migration defect in emc mutants (Cubas et al., 1994). In summary, the analysis of the embryonic functions of emc has shown that emc not only represses dierentiation but it plays positive roles, like favoring muscle development, although mechanistically it behaves as a negative regulator of other proteins. Emc represses the initiation of neural dierentiation in the eye The initial steps of dierentiation in the Drosophila eye, similar to the determination of the SMCs, depend on the activity of bHLH proteins, which is counteracted Oncogene by HLH repressors. The eye of Drosophila comprises about 750 ommatidia, each composed of eight photoreceptor and several support cells. These cells dierentiates in the eye imaginal disc in a stereotyped order behind the so-called morphogenetic furrow (MF) (Ready et al., 1976). The proneural bHLH gene atonal (ato) is required, in combination with Da, for the speci®cation of R8 (Jarman et al., 1994), the ®rst photoreceptor to develop and the one that subsequently recruits the other photoreceptors into the developing ommatidium (Freeman, 1997). ato is ®rst weakly expressed in a dorsoventral stripe of cells anterior and within the MF, and later is upregulated, ®rst in proneural clusters, and, ®nally, in the R8 cells (Dokucu et al., 1996). The expression and activity of ato is negatively regulated by Emc and Hairy, a bHLH transcriptional repressor, which are expressed anterior to the MF (Brown et al., 1995). Thus, whereas clones of cells lacking either h or emc function alone have only subtle eects on photoreceptor cell development, combined loss of emc and h causes upregulation of ato and the subsequent dierentiation of photoreceptor cells, in much anterior positions than in the adjacent wild type tissue (Brown et al., 1995). These observations suggest that a reduction on emc and h levels is a major prerequisite for the initiation of eye development. This is precisely the case. Recently it has been shown that downregulation of h and emc is controlled by the Notch signaling pathway, which is activated in the eye disc cells anterior and close to the MF in response to Hedgehog secreted by the already dierentiated photoreceptors (Baonza and Freeman, 2001). emc and vein dierentiation The Drosophila wing displays a stereotyped pattern of ®ve longitudinal veins and two transverse veins. This pattern is established in the imaginal wing disc by the combined action of the Notch and EGFR signaling pathways (reviewed in de Celis, 1998). Expression of veinlet/rhomboid (ve/rho) in prevein regions helps to locally activate the EGFR/Ras pathway, which is instrumental to promote vein formation. EGFR/Ras activates Delta in the veins, which binds to and activates Notch at the cells ¯anking the veins. The Notch pathway in turn activates transcription of E(spl)mb, which encodes a bHLH protein that represses expression of ve/rho and prevents the acquisition of vein fate in the cells ¯anking the proveins. The shape and position of emc clones in the wing and the pattern of expression of emc suggests a role for this gene in vein dierentiation. Thus, clones of cells hypomorphic for emc are elongated, frequently appear to run along the veins and they also can dierentiate ectopic veins of normal thickness (Baonza and Garcõ aBellido, 1999; Baonza et al., 2000; de Celis et al., 1995; Garcõ a-Alonso and Garcõ a-Bellido, 1988). In the pupal wing emc is expressed at highest levels in the intervein cells ¯anking the veins (Baonza et al., 2000). These are the cells where Notch signaling is maximally active and Multiples requirements for Emc in development S Campuzano indeed, expression of emc coincides with that of E(spl)mb (Baonza et al., 2000). Moreover, Baonza et al. (2000) demonstrated that Notch signaling is required from the beginning of pupal development to establish emc transcription pattern. This regulatory interaction may account for the observation that, although the phenotype of emc clones is dierent to that associated to loss-of-function alleles of Notch, which cause the formation of thicker veins but not the appearance of ectopic veins, however, when Notch signaling is compromised, vein dierentiation becomes very sensitive to reductions in emc function (Baonza et al., 2000). Moreover, both Emc and E(spl)mb cooperate in the repression of ve (Baonza et al., 2000). Since Emc and E(spl)mb do not physically interact (Baonza et al., 2000), Emc may titrate a protein that inhibits the transcriptional activity of an unidenti®ed factor which co-operates with E(spl)mb in the repression of ve/rho (Figure 2c,d). These observations and those presented above concerning eye development, are the ®rst indications of how the function of an Id-family protein, Emc, is integrated with that of an upstream signaling pathway, the Notch pathway, which plays a crucial and evolutionarily conserved role in the control of cell determination (reviewed in Artavanis-Tsakonas et al., 1999). Emc regulates cell proliferation Cooperation of emc and the Notch pathway also operates in the control of cell proliferation. In the wing disc, cell lacking emc function do not survive but those harboring strong hypomorphic emc alleles can proliferate, albeit to a reduced rate compared to wild type cells (Baonza and Garcõ a-Bellido, 1999; de Celis et al., 1995; Garcõ a-Alonso and Garcõ a-Bellido, 1988). Loss of Notch function similarly reduces cell viability (de Celis and Garcõ a-Bellido, 1994). Moreover, in the wing anlage cells doubly mutant for both emc and Notch have extremely poor viability suggesting that emc and the Notch pathway cooperate to promote cell proliferation (Baonza et al., 2000). This interaction does not rely on Notch controlling emc transcription. Thus, it has been proposed that emc and Notch signaling act in parallel, possibly on the same set of downstream genes, to promote cell proliferation (Baonza et al., 2000). In cultured ®broblasts, Id proteins positively control cell cycle progression at mid-late G1 phase by several ways (reviewed in Norton, 2000). Namely, Id proteins can relieve the inhibitory interaction of pRB with E2F, a factor required for the transcription of S phase genes. Additionally, Ids interfere with the transcriptional activation by bHLH proteins of the cyclindependent kinase inhibitor p21WAF1/CIP1. Since mechanisms controlling cell cycle progression are evolutionarily conserved, it is safe to speculate that Emc may act similarly in controlling the cell cycle in ¯ies. Con®rmation of this hypothesis awaits future experimentation. Regulation of transcription and translation of Emc 8305 The above results indicate that the pattern of expression of emc and the level of accumulation of Emc protein must be ®nely controlled during development. Although this is a relevant issue, not much is known of the regulation of emc. The clustering of emc regulatory mutations, mostly P-element insertions, in a rather short stretch of DNA (Ellis et al., 1990; Garrell and Modolell, 1990) argues against the existence of extended cis regulatory regions. However, the fact that emc mutations associated to chromosomal breakpoints map at considerable distance from the emc promoter, suggests otherwise (Garrell and Modolell, 1990). Importantly, emc transcription is not regulated by the AS-C (Cubas and Modolell, 1992). As indicated above, Notch pathway regulates emc expression, although in opposite ways in dierent tissues: it represses emc transcription in the eye disc (Baonza and Freeman, 2001) while activates it at the prospective wing margin region of the wing imaginal disc and at the vein/ intervein boundaries in pupal wings (Baonza et al., 2000). Although the direct eector is unknown, in the latter case it is known to be distinct from E(spl)mb (Baonza et al., 2000). The polychaetoid (pyd) mutation (also called Tamou, a Japanese term for `hairy') gives rise to ectopic SOs resembling the phenotype of insuciency of emc (Chen et al., 1996; Takahisa et al., 1996). Moreover, Pyd and emc mutations act synergistically in the development of extra veins and SOs (Takahisa et al., 1996). pyd ectopic bristles are due to the formation of additional SMCs (Chen et al., 1996; Takahisa et al., 1996) which appear to result from reduced transcription of emc in pyd mutant discs (Takahisa et al., 1996). Pyd is a PDZ domain protein whose sequence is closely related to mammalian Zona occludens proteins ZO-1, ZO-2 and ZO-3, members of the membrane-associated guanylate kinase homologue (MAGUK) family (reviewed in Dimitratos et al., 1999). Since Pyd is associated with septate and adherens junctions (Takahisa et al., 1996; Wie and Ellis, 2001), its role in emc regulation cannot be a direct one. The presence of multiple protein ± protein interaction domains in PDZ proteins allows them to act as scaolding components to organize protein complexes (Dimitratos et al., 1999). Accordingly, it has been suggested that Pyd participates in a signaling pathway that ultimately activates emc expression (Takahisa et al., 1996). Analysis of another mutation that aects the adult pattern of SOs, Bearded, provided indirect evidence for a postranscriptional regulation of emc. Bearded contains in their 3' untranslated region (UTR) several copies of two heptanucleotide sequence motifs, the Brd box (AGCTTTA) and the GY box (GTCTTCC). Mutant Brd transcripts that are truncated in the 3' UTR due to a transposon insertion and consequently lack two of the three Brd boxes and the GY box, are present at elevated steady-state levels. This is consistent with these motifs functioning to destabilize the Oncogene Multiples requirements for Emc in development S Campuzano 8306 wild-type transcript (Leviten et al., 1997). The Brd box may also aect translational eciency (Lai and Posakony, 1997). emc contains in its 3' UTR a single Brd box and four copies of a GY box-related sequence (GTTTTCC) (Lai and Posakony, 1997). A role of these sequences in emc mRNA stability is supported by the Achaetous mutation: This gain-offunction mutation is associated with the insertion of the transposable element Tirant in the ®rst exon of emc (Garrell and Modolell, 1990) and levels of emc transcripts are increased in Achaetous imaginal discs (Cubas and Modolell, 1992). It is unknown how these RNA sequences regulate translation and/or mRNA stability: regulatory proteins may bind to these sequences and regulate messenger activity or stability or, alternatively, formation of RNA : RNA heteroduplexes may regulate mRNA function (Lai and Posakony, 1998). The Emc transcript may contain other domains susceptible of postranscriptional regulation. Thus, in vitro RNA binding experiments demonstrate that Hel-N1, a human protein highly similar to the product of the Drosophila elav gene, can bind to the 3' UTR of Id mRNA. Hel-N1 binding sequences are also present in the 3' UTR of the Drosophila emc mRNA (King et al., 1994). Elav is an RNA binding protein known to regulate splicing of several neural speci®c genes (Lisbin et al., 2001). It would thus be interesting to determine whether Elav, which accumulates in the neurons (Robinow and White, 1988), plays any role in the downregulation of Emc which appears necessary for neural development to proceed. Perspectives More than 10 years have passed since the molecular cloning of emc and Id, and we have gained some insights on the function of emc during Drosophila development. Emc provides a clear example of how cell determination relies on the cell's ability to respond to subtle dierences in the concentration of regulatory proteins. However, many unresolved questions remain. We do not know yet which bHLH proteins Emc does interact with in many of the development processes aected by emc mutations. We even do not know whether all of these Emc-interacting proteins are bHLH proteins. Such proteins can be identi®ed by means of the two-hybrid system and later should be functionally characterized by genetic analyses. Furthermore, genetic screens can be devised to look for genes that interact with emc, based for instance on the suppression or enhancement of the adult phenotype of the emc gain-of-function mutation Achaetous. Some of these approaches are currently under way and we can foresee the identi®cation of new Emc partners that may help to shed a light into parallel processes carried out by mammalian Id proteins. Acknowledgments I would like to thank J Modolell, M Ruiz-GoÂmez and J de Celis for comments on the manuscript. Support from DGICYT, Comunidad Auto noma de Madrid and an institutional grant from FundacioÂn RamoÂn Areces to the Centro de Biologõ a Molecular Severo Ochoa is acknowledged. References Aolter M and Shilo BZ. (2000). Curr. Opin. Cell Biol., 12, 731 ± 735. Armand P, Knapp AC, Hirsch AJ, Wieschaus EF and Cole MD. (1994). Mol. Cell. Biol., 14, 4145 ± 4154. Artavanis-Tsakonas S, Rand MD and Lake RJ. (1999). Science, 284, 770 ± 776. Baker B. (1989). Nature, 340, 521 ± 524. Balcells L, Modolell J and Ruiz-GoÂmez M. (1988). EMBO J., 7, 3899 ± 3906. Baonza A, de Celis JF and Garcõ a-Bellido A. (2000). Development, 127, 2383 ± 2393. Baonza A and Freeman M. (2001). Development, 128, 3889 ± 3898. Baonza A and Garcõ a-Bellido A. (1999). Mech. Dev., 80, 133 ± 146. Bate M. (1978). Handbook of Sensory Physiology. Vol 1X. M Jacobson (ed). New York, Springer. Baumann P and Skaer H. (1993). Development, (Suppl): 65 ± 76. Baylies MK, Bate M and Ruiz-GoÂmez M. (1998). Cell, 93, 921 ± 927. Benezra R, Davis RL, Lockshon D, Turner DL and Weintraub H. (1990). Cell, 61, 49 ± 59. Bodmer R, Carretto R and Jan YN. (1989). Neuron, 3, 21 ± 32. Botas J, Moscoso del Prado J and Garcõ a-Bellido A. (1982). EMBO J., 1, 307 ± 310. Oncogene Cabrera CV, Alonso MC and Huikeshoven H. (1994). Development,120, 3595 ± 3603. Brown NL, Sattler CA, Paddock SW and Carroll SB. (1995). Cell, 80, 879 ± 887. Cabrera CV, Martõ nez-Arias A and Bate M. (1987). Cell, 50, 425 ± 433. Carmena A, Bate M and JimeÂnez F. (1995). Genes Dev., 9, 2373 ± 2383. Carrera P, Abrell S, Kerber B, Walldorf U, Preiss A, Hogh M and JaÈckle H. (1998). Proc. Natl. Acad. Sci. USA, 95, 10779 ± 10784. Castanon I, Von Stetina S, Kass J and Baylies MK. (2001). Development, 128, 3145 ± 3159. Caudy M, Grell EH, Dambly-ChaudieÁre C, Ghysen A, Jan LY and Jan YN. (1988a). Genes Dev., 2, 843 ± 852. Caudy M, Vassin H, Brand M, Tuma R, Jan LY and Jan YN. (1988b). Cell, 55, 1061 ± 1067. Chen C-M, Freedman JA, Bettler DR, Manning SD, Giep SN, Steiner J and Ellis HM. (1996). Mech. Dev., 57, 215 ± 227. Cline TW. (1988). Genetics, 119, 829 ± 862. Cline TW. (1989). Cell, 59, 231 ± 234. Cline TW and Meyer BJ. (1996). Annu. Rev. Genet., 30, 637 ± 702. Cubas P and Modolell J. (1992). EMBO J., 11, 3385 ± 3393. Cubas P, de Celis JF, Campuzano S and Modolell J. (1991). Genes Dev., 5, 996 ± 1008. Multiples requirements for Emc in development S Campuzano Cubas P, Modolell J and Ruiz-GoÂmez M. (1994). Development, 120, 2555 ± 2566. Dambly-ChaudieÁre C, Ghysen A, Jan LY and Jan YN. (1988). Roux's Arch. Dev. Biol., 197, 419 ± 423. Davis RL, Cheng PF, Lassar AB and Weintraub H. (1990). Cell, 60, 733 ± 746. de Celis JF. (1998). Int. J. Dev. Biol., 42, 335 ± 343. de Celis JF and Garcõ a-Bellido A. (1994). Mech. Dev., 46, 109 ± 122. de Celis JF, Baonza A and Garcõ a-Bellido A. (1995). Mech. Dev., 53, 209 ± 221. Dimitratos SD, Woods DF, Stathakis DG and Bryant PJ. (1999). BioEssays, 21, 912 ± 921. Dokucu ME, Zipursky SL and Cagan RL. (1996). Development, 122, 4139 ± 4147. Ellis HM. (1994). Mech. Dev., 47, 65 ± 72. Ellis HM, Spann DR and Posakony JW. (1990). Cell, 61, 27 ± 38. Erickson JW and Cline TW. (1991). Science, 251, 1071 ± 1074. Erickson JW and Cline TW. (1993). Genes Dev., 9, 1688 ± 1702. Freeman M. (1997). Development, 124, 261 ± 270. Garcõ a-Bellido A. (1979). Genetics, 91, 491 ± 520. Garcõ a-Alonso LA and Garcõ a-Bellido A. (1988). Roux's Arch. Dev. Biol., 197, 328 ± 338. Garcõ a-Bellido A and Merriam J. (1971). Develop. Biol., 24, 61 ± 87. Garcõ a-Bellido A and Santamarõ a P. (1978). Genetics, 88, 469 ± 486. Garrell J and Campuzano S. (1991). BioEssays, 13, 493 ± 498. Garrell J and Modolell J. (1990). Cell, 61, 39 ± 48. Ghysen A and Dambly-ChaudieÁre C. (1989). Trends Genet., 5, 251 ± 255. GoÂmez-Skarmeta JL, Rodrõ guez I, Martõ nez C, Culõ J, FerreÂs-Marco MD, Beamonte D and Modolell J. (1995). Genes Dev., 9, 1869 ± 1882. Hartenstein V and Posakony JW. (1989). Development, 107, 389 ± 405. Hoch M, Broadie K, JaÈckle H and Skaer H. (1994). Development, 120, 3439 ± 3450. Jan YN and Jan LY. (1993). Cell, 75, 827 ± 830. Jarman AP, Grell EH, Ackerman L, Jan LY and Jan YN. (1994). Nature, 369, 398 ± 400. Kageyama R and Nakanishi S. (1997). Curr. Opin. Genet. Dev., 7, 659 ± 665. King PH, Levine TD, Fremeau Jr RT and Keene JD. (1994). J. Neurosci., 14, 1943 ± 1952. Lai EC and Posakony JW. (1997). Development, 124, 4847 ± 4856. Lai EC and Posakony JW. (1998). Cell, 93, 1103 ± 1104. Lee T, Hacohen N, Krasnow M and Montell D. (1996). Genes Dev., 10, 2912 ± 2921. Leviten MW, Lai EC and Posakony JW. (1997). Development, 124, 4039 ± 4051. Lisbin MJ, Qiu J and White K. (2001). Genes Dev., 15, 2546 ± 2561. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K and Benezra R. (1999). Nature, 401, 670 ± 677. Martõ nez C, Modolell J and Garrell J. (1993). Mol. Cell. Biol., 13, 3514 ± 3521. Massari ME and Murre C. (2000). Mol. Cell. Biol., 20, 429 ± 440. Modolell J and Campuzano S. (1998). Int. J. Dev. Biol., 42, 275 ± 282. Moscoso del Prado J and Garcõ a-Bellido A. (1984a). Roux's Arch. Dev. Biol., 193, 246 ± 251. Moscoso del Prado J and Garcõ a-Bellido A. (1984b). Roux's Arch. Dev. Biol., 193, 242 ± 245. Murre C, McCaw PS and Baltimore D. (1989a). Cell, 56, 777 ± 783. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV and Baltimore D. (1989b). Cell, 58, 537 ± 544. Norton JD. (2000). J. Cell Sci., 113, 3897 ± 3905. Ohshiro T and Saigo K. (1997). Development, 124, 3975 ± 3986. Parkhurst SM, Bopp D and Ish-Horowicz D. (1990). Cell, 63, 1179 ± 1191. Ready DF, Hanson TE and Benzer S. (1976). Dev. Biol., 53, 217 ± 240. Robinow S and White K. (1988). Dev. Biol., 126, 294 ± 303. Rodrõ guez I, HernaÂndez R, Modolell J and Ruiz-GoÂmez M. (1990). EMBO J., 9, 3583 ± 3592. Romani S, Campuzano S, Macagno E and Modolell J. (1989). Genes Dev., 3, 997 ± 1007. Skaer H. (1993). The development of Drosophile melanogaster. Martõ nez-Arias A and Bate M (eds). Cold Spring Harbor Lab. Press. New York. Cold Spring Harbor. Skeath JB and Carroll SB. (1991). Genes Dev., 5, 984 ± 995. Takahisa M, Togashi S, Suzuki T, Kobayashi M, Murayama A, Kondo K, Miyake T and Ueda R. (1996). Genes Dev., 10, 1783 ± 1795. Torres M and SaÂnchez L. (1989). EMBO J., 8, 3079 ± 3086. Torres M and SaÂnchez L. (1991). Development, 113, 715 ± 722. Van Doren M, Ellis HM and Posakony JW. (1991). Development, 113, 245 ± 255. Van Doren M, Powell PA, Pasternak D, Singson A and Posakony JW. (1992). Genes Dev., 6, 2592 ± 2605. Villares R and Cabrera CV. (1987). Cell, 50, 415 ± 424. Voronova A and Baltimore D. (1990). Proc. Natl. Acad. Sci. USA, 87, 4722 ± 4726. Wie X and Ellis HM. (2001). Mech. Dev., 100, 217 ± 231. Younger-Shepherd S, Vaessin H, Bier E, Jan LY and Jan YN. (1992). Cell, 70, 911 ± 922. 8307 Oncogene
© Copyright 2025 Paperzz